Abstract: The present invention relates to the use of a peptide, or derivative thereof of general formula X1—X2—X3-Thr-X4-Lys-X5-Arg-X6 for promoting accelerated wound healing with reduced scarring. X1 is Ala or Gly; X2 is Tyr or Phe; X3, X4 and X5 are independently selected from the group comprising Met, Ile, Leu and Val; and X6 is selected from the group comprising Asp, Gln and Glu.

Abstract: In accordance with embodiments, there are provided mechanisms and methods for facilitating evaluation of data types for dynamic lightweight objects in an on-demand services environment. In one embodiment and by way of example, a method includes uploading a data file having data at a first computing device in response to a request, and detecting data types relating to the data within the data file. The detecting includes scanning data rows and data columns of the data file. The method may further include classifying the detected data types into one or more categories, and creating one or more dynamic objects based on the one or more categories.

Abstract: An ambulatory device for use in a therapeutic and/or cosmetic treatment, the device comprises an organic light-emitting semiconductor which, in use, covers an area to be treated and emits electromagnetic radiation to cause said therapeutic and/or cosmetic treatment of the area. The light source may be extensive to provide uniform irradiation of the area to be treated and may be pulsed. The device may also include a photopharmaceutical.

Abstract: In accordance with embodiments, there are provided mechanisms and methods for facilitating conversion and correction of data types for dynamic lightweight objects via a user interface in an on-demand services environment. In one embodiment and by way of example, a method includes receiving a first data file at a first computing device, identifying data types in the first data file that correspond to dynamic custom objects associated with the first data file, and linking the data types to their corresponding dynamic custom objects.

Abstract: In accordance with embodiments, there are provided mechanisms and methods for facilitating evaluation of data types for dynamic lightweight objects in an on-demand services environment. In one embodiment and by way of example, a method includes uploading a data file having data at a first computing device in response to a request, and detecting data types relating to the data within the data file. The detecting includes scanning data rows and data columns of the data file. The method may further include classifying the detected data types into one or more categories, and creating one or more dynamic objects based on the one or more categories.

Abstract: An explosive composition comprising a liquid energetic material and sensitizing voids, wherein the sensitizing voids are present in the liquid energetic material with a non-random distribution, wherein the liquid energetic material comprises (a) regions in which the sensitizing voids are sufficiently concentrated to render those regions detonable and (b) regions in which the sensitizing voids are not so concentrated and wherein the explosive composition does not contain ammonium nitrate prill.

Abstract: Abrasion resistant coatings useful for improving abrasive wear and/or corrosion resistance in radial bearings and downhole tools exposed to drilling forces as well as abrasive and/or corrosive drilling fluids. An abrasion resistant coating is disposed on at least one surface of a component body to increase the resistance of the component to abrasive wear and corrosion. The abrasion resistant coating includes a plurality of spherical tungsten cobalt carbide particles and a plurality of tungsten carbide particles. At least 65% by volume of the spherical tungsten cobalt carbide particles have a diameter of less than about 25 microns.

Abstract: In accordance with embodiments, there are provided mechanisms and methods for facilitating evaluation of data types for dynamic lightweight objects in an on-demand services environment. In one embodiment and by way of example, a method includes uploading a data file having data at a first computing device in response to a request, and detecting data types relating to the data within the data file. The detecting includes scanning data rows and data columns of the data file. The method may further include classifying the detected data types into one or more categories, and creating one or more dynamic objects based on the one or more categories.

Abstract: In accordance with embodiments, there are provided mechanisms and methods for facilitating conversion and correction of data types for dynamic lightweight objects via a user interface in an on-demand services environment. In one embodiment and by way of example, a method includes receiving a first data file at a first computing device, identifying data types in the first data file that correspond to dynamic custom objects associated with the first data file, and linking the data types to their corresponding dynamic custom objects.

Abstract: Systems and methods for facilitating contact information display, management and synchronization are described. A client application on a portable device in communication with a host system provides a mechanism for receiving, displaying, updating, processing and transmitting contact information and data to the host system, where it may then be synchronized with other devices associated with other users. The host system may also collect information from social networking sites and other locations to update and synchronize contact information and data.

Abstract: There is provided the use of mannose-6-phosphate, or a salt, precursor or analogue thereof, for providing and/or maintaining a consistent skin colour, particularly to reducing redness of skin. There is also provided the use of mannose-6-phosphate, or a salt, precursor or analogue thereof, as a skin improvement agent for providing a cosmetic effect and mannose-6-phosphate, or a salt, precursor or analogue thereof, for use in treating normal or damaged skin, wherein damaged skin is skin that has been subject to epidermal and/or dermal damage.

Abstract: Systems and methods for providing online sales, advertising, and information distribution are disclosed. A user may provide a request for a mobile advertisement or other mobile content by capturing images or other content associated with items to be listed, and enter and transmit a description of the item or other associated information, typically in the form of text or a text message, to a content management system. The information is then received by the content management system and processed and stored to quickly provide displays, listings, and/or messages associated with the content, based on criteria such as item description or type, location, and price.

Abstract: Provided is WNT3A, or a therapeutically effective fragment or derivative thereof, for use as a medicament for the prevention, reduction or inhibition of scarring. Also provided is a method of preventing, reducing or inhibiting scarring, the method comprising administering a therapeutically effective amount of WNT3A, or a therapeutically effective fragment or derivative thereof, to a patient in need of such prevention, reduction or inhibition. The methods and medicaments of the invention are suitable for use in the prevention, reduction or inhibition of scarring arising as a result of healing of a wound, or scarring associated with a fibrotic disorder. The methods and medicaments disclosed are of particular use in preventing, reducing or inhibiting scarring of the skin.

Abstract: A stormwater treatment system having a treatment container with two chambers, a treatment chamber and a bypass chamber. The bypass chamber includes an inlet for receiving stormwater. Disposed adjacent the inlet is an overflow tray secured to the walls of the bypass chamber. The tray includes an inlet opening for receiving the stormwater to be treated, and a discharge opening through the baffle wall that separates the two chambers for discharging stormwater that enters at low flow rates. The stormwater to be treated passes through the discharge opening into the treatment chamber where it is treated by the filter media. High flow rates will bypass the treatment chamber by overflowing a dam wall or weir defined by the overflow tray directly into the bypass chamber. Treated water from the treatment chamber passes through an underdrain pipe that enters into the bypass chamber. All water from the bypass chamber exits through pipe openings, preferably on each of three sides of the bypass chamber wall.

Abstract: The invention provides new methods of treatment using TGF-?3 to inhibit scarring in humans, and TGF-?3 for new uses in the inhibition of scarring in humans. In a first incidence of treatment TGF-?3 is provided to each centimetre of a wound margin or each centimetre of a site at which a wound is to be formed in a first therapeutically effective amount; and in a subsequent incidence of treatment TGF-?3 is provided to each centimetre of wound margin in a larger therapeutically effective amount of TGF-?3. The incidences of treatment occur between 8 hours and 48 hours apart from one another. The TGF-?3 may be provided by intradermal injection. Also provided are kits and methods of selecting an appropriate treatment regime for inhibiting scarring associated with the healing of a human wound.

Abstract: The invention provides new methods of treatment using TGF-?3 to inhibit scarring in humans, and TGF-?3 for new uses in the inhibition of scarring in humans. In a first incidence of treatment each centimetre of wound margin, or each centimetre of a site at which a wound is to be formed, is provided with between approximately 350 ng and 1000 ng of TGF-?3; and in a second incidence of treatment, occurring after a wound is formed, and between 8 and 48 hours after the first incidence of treatment, the wound is provided with an amount of between approximately 350 ng and 1000 ng of TGF-?3 per centimetre of wound margin in which scarring is to be inhibited. The amount of TGF-?3 provided may be the same in each incidence of treatment. The amount of TGF-?3 provided per centimetre in each incidence of treatment may preferably be approximately 500 ng. The TGF-?3 may be provided by intradermal injection.

Abstract: The invention provides TGF-?3s, or fragments or derivatives thereof, wherein the alpha-helix-forming domain between amino acid residues (58) and (67) of full-length wild type TGF-?3 comprises at least one alpha-helix-stabilizing substitution. The invention also provides TGF-?3s, or fragments or derivatives thereof, wherein the Glycine residue at position (63) of full-length wild type TGF-?3 is replaced with Proline. Further still, the invention provides TGF-?3s, or fragments or derivatives thereof, comprising a substitution of the Glutamic acid residue at position (12) of full-length wild type TGF-?3 and/or the Arginine residue at position (52) of full-length wild type TGF-?3. The invention also provides medicaments and methods of treatment using such TGF-?3s.

Abstract: A method and apparatus for determining the efficacy of a medicament for the treatment of wounds or scars. The method comprises selecting first and second scarring site portions wherein said first scarring site portion has been treated with said medicament. A pair of images comprising a first image of said first scarring site portion and a second image of said second scarring site portion is generated, and the pair of images is displayed. A recording element comprising first and second recording portions is provided, wherein said first recording portion comprises a plurality of first points indicating that scarring in said first image is less severe than scarring in said second image, and said second recording portion comprises a plurality of second points indicating that scarring in said second image is less severe than scarring in said first image, each of said first and second points having different associated values.

Abstract: The invention provides TGF-?3s, or fragments or derivatives thereof, wherein the alpha-helix-forming domain between amino acid residues (58) and (67) of full-length wild type TGF-?3 comprises at least one alpha-helix-stabilising substitution. The invention also provides TGF-?3s, or fragments or derivatives thereof, wherein the Glycine residue at position (63) of full-length wild type TGF-?3 is replaced with Proline. Further still, the invention provides TGF-?3s, or fragments or derivatives thereof, comprising a substitution of the Glutamic acid residue at position (12) of full-length wild type TGF-?3 and/or the Arginine residue at position (52) of full-length wild type TGF-?3. The invention also provides medicaments and methods of treatment using such TGF-?3s.

Abstract: An oxidation process for the production of alkenes and carboxylic acids from a feed comprising alkene and/or alkane, carbon monoxide, a molecular oxygen containing gas and optionally water in the presence of an oxidation catalyst in which the level of carbon monoxide is maintained between 1% and 20% by volume of the total feed to the reactor.